Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Benlysta Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

globenewswire.com

Benlysta Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Benlysta Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering.

The report offers insights into Benlysta's uses, sales forecasts, mechanism of action, and potential indications across major global markets, including the U.S., Europe, and Japan. It provides a comprehensive examination of current and future market scenarios, placing emphasis on research, development, and the competitive landscape.

Benlysta (Belimumab) is a recombinant monoclonal antibody for systemic lupus erythematosus (SLE) and lupus nephritis, targeting B-lymphocyte stimulator. Clinical trials demonstrate its efficacy in reducing disease activity and flares, generally well tolerated with common side effects including nausea and fever.

GSK has enhanced production capacity for Benlysta, investing $139 million in its Maryland site as of 2017. These developments underpin the subcutaneous form's support.

Key Factors Driving Benlysta Growth

Strong and Sustained Sales Growth Momentum

First-in-Class BLyS (BAFF) Inhibitor

Expansion into Lupus Nephritis

Shift Toward Subcutaneous Administration

Increasing Adoption of Biologics

Benlysta Recent Developments

Scope of the Benlysta Market Report

Key Questions

For more information about this report visit https://www.researchandmarkets.com/r/tzwzxx

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.